Overall description of bone metabolism.
Introduction
Types of bone tissue
Composition of bone
Cells of bone
Regulators of bone metabolism
Calcium and phosphate balance
Calcium and phosphate
Parathyroid hormone
Calcitonin
Vitamin D
Fibroblast growth factor
Growth hormone and IGF-1
Thyroid hormone
Estrogens, progesterone and androgens
Cortisol and related glucocorticoids
Disorders of bone metabolism
Orthodontic considerations
Overall description of bone metabolism.
Introduction
Types of bone tissue
Composition of bone
Cells of bone
Regulators of bone metabolism
Calcium and phosphate balance
Calcium and phosphate
Parathyroid hormone
Calcitonin
Vitamin D
Fibroblast growth factor
Growth hormone and IGF-1
Thyroid hormone
Estrogens, progesterone and androgens
Cortisol and related glucocorticoids
Disorders of bone metabolism
Orthodontic considerations
Bone metabolism and calcium homeostasisAhmed Madni
Bone is a metabolically active tissue that undergoes constant remodeling. The major cells involved in the remodeling process are osteoclasts and osteoblasts. Bone metabolism is closely interrelated with the metabolism of calcium, which also involves the intestine and kidney. Calcium balance is hormonally regulated by parathyroid hormone, vitamin D metabolites and calcitonin.
Bone metabolism and calcium homeostasisAhmed Madni
Bone is a metabolically active tissue that undergoes constant remodeling. The major cells involved in the remodeling process are osteoclasts and osteoblasts. Bone metabolism is closely interrelated with the metabolism of calcium, which also involves the intestine and kidney. Calcium balance is hormonally regulated by parathyroid hormone, vitamin D metabolites and calcitonin.
Calcium metabolism disorders
1. CALCIUM METABOLISM DISORDERS
2. OVERVIEW: Calcium definition and requirement . Calcium metabolism regulators : VD , PTH and calcitonin. Functions of calcium. Calcium metabolic bone diseases. Calcium metabolism disorders. CASE !!
3. WHAT IS CALCIUM? Calcium is a mineral that is essential to bone health, cardiovascular health, muscle maintenance, circulatory health, and blood clotting. Calcium also acts as an enzyme activator. While calcium is found in milk and dairy products, it is also available from other food sources, such as green leafy vegetables, seafood (eating salmon with the bones provides an even greater dose), almonds, blackstrap molasses, broccoli, enriched soy and rice milk products, figs, soybeans and tofu.
This presentation deals with the physiological aspect of Calcium and phosphate metabolism, it's relationship with the various types of rickets and possible remedies
Similar to Bone metabolism by Dr. binod Chaudhary.pptx (20)
Common diseases of ear, nose and throat prevalent in community level populaton of Nepal.
These are the most common conditions that the people present in primary health center level.
The slide includes the short introduction and management of those conditions and primary preventive measures in case they are far away from well equipped hospitals.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
2. Contents
• Composition of bone
• Distribution of calcium and phosphate in human body
• Serum calcium and phosphate measurement
• Dietary sources and requirements of calcium and phosphate
• Calcium and phosphate absorption and excretion
• Calcium and phosphate homeostasis
• Hormonal control of calcium and phosphate ion concentration
• Hypercalcemia and hypocalcemia
• Bone health
• Calcium supplements
5. DISTRIBUTION OF CALCIUM IN THE HUMAN
BODY
• Calcium constitutes 2% of the body weight- approx. 1.2 kg
• 0.1% is in the extracellular fluid
• 1% in the cells
• More than 99% stored in bones
Distribution of Serum Calcium
Ionized (or free)
calcium
Calcium bound to
albumin
Calcium complexed
with citrate, sulfate,
or phosphate
45%
40%
15%
6. Serum calcium measurements
• Normal serum calcium concentration is 8.6-10.3 mg/dL
(2.15-2.54 mmol/L).
• Normal ionized calcium concentration is 4.4-5.2 mg/dL.
• In general, measuring total serum calcium is sufficient.
• However, this can be misleading in certain situations.
• Thus, measurement of ionized calcium is the gold standard
for assessing calcium status.
7. • Conditions in which total calcium can change without
affecting ionized calcium:
– Hypoalbuminemia (decreased total calcium)
– Hyperalbuminemia (increased total calcium)
– Multiple myeloma (increased total calcium)
• Conditions in which ionized calcium can change without
affecting total calcium:
– Acid-base disorders (increased pH leads to decreased
ionized calcium)
– Hyperphosphatemia (decreased ionized calcium)
– Hyperparathyroidism (increased ionized calcium)
11. Dietary requirements
ELEMENTAL CALCIUM PER
DAY
Children 600 mg
Adolescents and young adults (10-25 yrs) 1300mg
Adults ages 25050 yrs 750 mg
Over age 50 years 1200-1500 mg
Pregnant women 1500 mg
Lactating women 2000 mg
Post menopausal women and the patient with
healing fractures
1500 mg
12. CALCIUM ABSORPTION AND EXCRETION
• Absorbed in the duodenum by active transport
(transcellular pathway).
– Requires ATP and calcium binding protein
– Regulated by 1,25-(OH)2D3
• Absorbed in the jejunum by passive diffusion
(paracellular pathway)
• Average daily consumption is about 1000 mg, of
which 350 mg is absorbed and the rest (650 mg)
is excreted in feces.
• Further 250 mg is secreted in GI secretions and
excreted in feces, thus 90% (900 mg/day) is
excreted in feces.
13. CALCIUM ABSORPTION AND EXCRETION
• Absorption is inhibited by:
– Excessive intake of phosphates (in soft drinks)
– Oxalates (in tea and coffee)
– Fats
– Certain drugs such as corticosteroids
– Intestinal malabsorption disorders
• 98% of filtered calcium is absorbed by the kidneys (60% in PCT).
• Approx. 100 mg is excreted daily in urine in the steady state.
• Approx. 400-500 mg of calcium is released from bone everyday and
the same amount is deposited.
14.
15. Phosphate
• In human body Phosphorus is present as Phosphate (compounds
containing the phosphate ion, PO4
---)
• Role of phosphate:
17. Phosphates
• Daily requirements
– Adults: 800 mg
– Pregnancy, lactation and children: 1200 mg
– Infants: 240 mg
• Sources of phosphate
• Rich (milk, meat, fish, poultry, eggs)
• Moderate (cereals, pulses, nuts, legumes)
• Reabsorbed by the kidney (proximal tubule)
• Phosphate may be excreted in urine
18. Calcium and Phosphate Homeostasis
There are 3 main players in the control of blood calcium levels
1. Vitamin D (Calcitriol)
2. Parathyroid hormone
3. Calcitonin
19.
20. VITAMIN D(CALCITRIOL)
• Has potent effect to increase calcium absorption from intestinal tract,
bone deposition and bone resorption.
• Cholecalciferol is formed in the skin
• Cholecalciferol is converted to 25-Hydroxycholecalciferol in the liver
• Formation of 1,25-Dihydroxycholecalciferol in the kidneys
• Calcium ion concentration controls the formation of 1,25-
Dihydroxycholecalciferol
21. Actions of Vitamin D
In Intestine:
• Two major mechanisms for calcium absorption
Between cells(paracellular):
passive
quantitative significance when intake is high
Through cells
active
influenced by calcitriol
calbindin: acts as an intracellular sink to reduce the microvilli[Ca]
22. On Bone:
Calcitriol → ↑no. and activity of osteoblasts; also ↑secretion of
ALP by osteoblasts → mineralization of bone
Mineralization of bones:
Calcitriol → Osteoblast → ↑Ca uptake for deposition as calcium
phosphate
On kidney:
calcitriol → ↓excretion and ↑reabsorption of Ca and P →
↑plasma Ca and P
23. VITAMIN D DEFICIENCY
• Deficiency leads to osteomalacia in adults and rickets in children.
• Decreased vitamin D, decreased serum calcium and phosphate,
increased PTH and ALP seen.
• Causes of vitamin D deficiency:
– Inadequate dietary intake
– Intestinal malabsorption
– Lack of sunlight exposure
– Impaired 25-hydroxylation in liver disease
– Impaired 1-alfa hydroxylation in renal disease
24. RICKETS
• Defective mineralization of cartilagenous growth plate, causing chondrocytes to pile up
irregularly, increase in width of growth plate, poor mineralization of the zone of
calcification and sparse bone formation in the zone of ossification.
• Clinical features:
– Tetany or convulsions
– Bow legs (genu varum)
– Bead-like costochondral junctions (rachitic rosary)
– Craniotabes (soft skull)
– Harrison’s sulcus (lateral indentation of the chest)
• X-ray:
– Epiphyseal widening and metaphyseal cupping/fraying
– Bowing of the diaphysis
25.
26. OSTEOMALACIA
• Defective mineralization of osteoid due to deficiency of vitamin D.
• Increased bone fragility and fracture risk.
• Clinical features:
– Bone pain
– Muscle weakness
– Waddling gait
• X-ray:
– Looser zone, a thin transverse band of rarefaction in an otherwise normal-
looking bone
– Vertebral fractures may show characteristic biconcave appearance
– Champagne glass pelvis
27.
28. PTH- Parathyroid glands
• Secretion of PTH is under negative feedback regulation by S Ca.
Low S Ca → ↑ PTH secretion
Action on Bone- Demineralization or decalcification of bone by
osteoclasts (bone resorption)
• Quantitatively most important action
Action on kidney- ↑Ca reabsorption in DCT→↑S Ca
• Most rapid but quantitatively less important as compared to action on bone
(PTH at PCT→decreases PO4 reabsorption→↑U excretion →decreases S
phosphate)
Action via Calcitriol- By activation of activity of 1α-hydroxylase→on
intestine, bone and kidney →↑S Ca
29.
30. HYPOPARATHYROIDISM
• Low PTH levels with decreased serum calcium and increased
serum phosphate.
• Causes:
• Hypoparathyroidism most commonly follows thyroidectomy
• Autoimmune disease
• Magnesium deficiency
• DiGeorge syndrome
• Pseudohypoparathyroidism
• Rare genetic disorder caused by impaired peripheral sensitivity to PTH
• PTH normal or high
• Albright’s hereditary osteodystrophy (short stature, short 4th and 5th
metacarpals and mild mental retardation)
31. HYPERPARATHYROIDISM
• Increased PTH levels with increased serum calcium and decreased serum
phosphate.
• Types:
• Primary (usually due to an adenoma or hyperplasia).
• Secondary (due to persistent hypocalcemia leading to parathyroid hyperplasia).
• Tertiary (when secondary hyperplasia leads to autonomous overactivity).
• Treatment:
• Adequate hydration and decreased calcium intake
• Parathyroidectomy for primary hyperparathyroidism
32. RENAL OSTEODYSTROPHY
• Is a form of metabolic bone disease seen in patients with chronic
renal insufficiency characterized by bone mineralization deficiency
due to electrolyte and endocrine abnormalities.
• The dominant picture may be that of secondary hyperparathyroidism
(due to phosphate retention, hypocalcemia, and diminished
production of vit D3), osteoporosis, osteomalacia, - or in advance
cases- a combination of these.
• The effects may be superimposed with postmenopausal osteoporosis,
glucocorticoid medication or aluminium retention in dialysis fluids
33. PATHOPHYSIOLOGY
CHRONIC KIDNEY DISEASE
DECREASED TUBULAR FILTRATION DECREASED GLOMERULAR FILTRATION
HYPERPHOSPHATEMIA
DECREASED SYNTHESIS OF ACTIVE FORM OF VIT D
HYPOCALCEMIA
SECONDARY HYPERPARATHYROIDISM
LEECHING OF CALCIUM FROM BONES TO COMPENSATE FOR SERUM HYPOCALCEMIA
DYSTROPHIC BONE WHICH IS SUSCEPTIBLE TO PATHOLOGIC FRACTURES
34. • Clinical features
• Weakness
• Bone pain
• Pathological fracture
• Skeletal deformity
• Symptoms of hpocalcemia
Treatment
• Treat the underlying renal condition.
35. Calcitonin
• Secreted by-parafollicular cells of Thyroid
• Calcitonin action on calcium is antagonistic to that of PTH
1. Calcitonin promotes calcification by increasing activity of
osteoblasts[v/s PTH-decalcification]
2. Calcitonin ↓bone resorption by osteoclasts[v/s PTH- ↑bone
resorption by osteoclasts]
3. Calcitonin ↑Ca excretion in urine[v/s PTH-↑Ca reabsorption by
DCT]
36. ↑S Ca→ ↑Calcitonin and ↓PTH
↓S Ca→ ↓Calcitonin and ↑PTH→demineralization & effect on kidney
& PTH via 1α hydroxylase→↑S Ca
39. Other hormones affecting bone metabolism
Estrogen
prevents bone loss by inhibiting bone resorption (also decreases
bone formation)
Corticosteroids
increases bone loss
decreases gut absorption of Ca by ↓binding proteins
↓bone formation(cancellous>cortical) by inhibiting collagen
synthesis
do not affect mineralisation
40. Thyroid hormones
affect bone resorption>bone formation
regulates skeletal growth at the physis.
Growth hormone
positive Ca balance
41. Disorders in Calcium Homeostasis
Hypercalcemia
S. Ca >10.5 mg/dl
Hyporcalcemia
S. Ca <8.5 mg/dl
43. 2. Increased Calcium loss from Bone
• Increased bone resorption
• Elevated PTH (primary hyperparathyroidism, adenoma,
hyperplasia, carcinoma)
• Acidemia
• Malignancy
Increased bone turnover
Immobilization
Hyperthyroidism
Hypervitaminosis A/ retinoic acid
Paget’s disease of bone
44. 3. Decreased Bone Mineralization
• Aluminium intoxication- seen in end stage renal failure
• Elevated PTH
4. Decreased urinary calcium excretion
• Thiazide diuretics
• Familial hypocalciuric hypercalcemia
• Elevated calcitriol
5. Pseudohypercalcemia
• Severe dehydration
• Multiple myeloma
45. Hypocalcemia
Symptoms- irritability, muscle cramps, depression, psychosis, bronchospasm and
seizures
Signs- increased reflexes, prolonged QT interval on ECG
Chovstek’s sign: tapping of the facial nerve induces contraction of the facial muscles
Trousseau’s sign: inflation of blood pressure cuff induces carpal muscle spasm
Etiologies:
1. Decreased GI Absorption of Calcium
• Poor dietary intake of calcium
• Decreased GI absorption with normal dietary intake
2. Decreased calcitriol: causes
• Vitamin D deficiency (poor dietary intake, inadequate sunlight exposure, malabsorpton syn,
nephrotic syndrome)
• Decreased convertion of vitamin D to calcitriol (liver/kidney failure, low PTH)
46. 3. Vitamin D resistance
• Hereditary vitamin D resistant rickets
4. Increased bone mineralization
• Low PTH
• PTH resistance
• Hungry bone syndrome: the rapid mineralization of bones following
parathyroidectomy.
5. Decreased bone resorption
• Low PTH
• PTH resistance
6. Increased urinary excretion of calcium
47. Markers of Bone Remodeling
• Formation markers
• Alkaline phosphatase
• Serum osteocalcin
• Procollagen type 1
• Resorption markers
• Carboxyterminal (ICTP,CTX) and amino-terminal (NTX) telopeptides of
collagen
• Tartarate-resistant acid phosphatase
48. BONE HEALTH
• Calcium and vitamin D are important
for bone health because they can:
– Help keep bones strong
– Prevent bones from breaking easily,
especially in the spine
• People who do not have healthy bones can develop
osteoporosis.
• Eating enough calcium and vitamin D is important in
preventing osteoporosis and reducing bone loss, thus
decreasing the risk of fractures.
49. CALCIUM SUPPLEMENTS
• Calcium carbonate
– Effective and least expensive
– Best absorbed with a low-iron meal
– May not be well absorbed in patients taking PPI
• Calcium citrate
– Well absorbed in fasting state as well as with a meal
• Calcium doses above 500 mg are not absorbed well, so large
doses of supplements should be taken in divided doses.
• Calcium supplements don’t replace other osteoporosis
treatments such as hormone replacement and
50. References
• Miller’s Review of Orthopaedics, 8th edition
• Apley & Solomon’s System of Orthopaedics and Trauma,
10th edition
• Guyton and Hall Textbook of Medical Physiology, 12th
edition
• Netter’s Concise Orthopaedic Anatomy 2nd Edition
Cells:
Osteoblasts- Bone forming cells.
Osteocytes- maintain bone. 90% in mature skeleton.
Osteoclasts- Bone resorption cells
Matrix
Organic- mainly type I collagen fibers
Inorganic matrix- Ca++,Mg++, phosphates, carbonates, chloride, fluoride and citrate.
Collagen- type 1 collagen- tensile strength
Proteoglycans- macromolecules- made up of hyaluronic backbone with multiple GAGs(GAGs are made of chondroitin and keratin bodies)
Osteocalcin (indicator of backbone turnover-paget’s disease)
Rigidity of bone is maintained by inorganic contents
Lack of inorganic content- soft bone (rickets/osteomalacia)
Organic content give elasticity to the bone.
Lack of organic contents- brittle bone(Osteogenesis Imperfecta)
Absorbed in duodenum by active transport requiring ATP and calcium binding protin and regulated by calcitriol.
Absorbed in jejunum by passive transport
Role of phosphate:
A key constituent of bone and teeth
Components of intracellular buffering. Forms energy rich bonds in ATP
Forms coenzymes
Regulates blood and urinary pH
Forms organic molecules like DNA and RNA
Cellular energy metabolism
Alternate day corticosteroid therapy reduce these effects.
Large doses of thyroxine can lead to osteoporosis.
At physis, thyroid hormones stimulate chondrocyte growth, type X collagen synthesis, and alkaline phosphatase activity.
GH causes positive calcium balance by increasing gut absorption of calcium more than it increases urinary excretion.
Pseudohypercalcemia due to increased protein binding of calcium in hyperprotein states